Xue-Fu-Zhu-Yu capsule in the treatment of qi stagnation and blood stasis syndrome: a study protocol for a randomised controlled pilot and feasibility trial

DiscussionPrevious studies were expected to evaluate whether the addition of XFZYC to standard routine treatment would enhance the treatment effectiveness and improve the biomedical parameters pertaining to relevant disease. However, this trial is focused on the outcome ofZhengs, and we chose a range of outcome measurements to assess the improvement of relevant symptoms and signs. This trial is the first study designed to define and optimise the outcome measurements ofZhengs of XFZYC in the treatment of patients with QS&BSS.Trial registrationClinicalTrials.gov,NCT03091634. Registered on 12 August 2018. Release date 6 May 2017.
Source: Trials - Category: Research Source Type: clinical trials